Bone Morphogenetic Protein Market Analysis By Type (rhBMP-2, rhBMP-7), By Application (Spinal Fusion, Trauma, Reconstruction, Oral Maxillofacial Surgery), By Region (North America, Europe, APAC, LATAM, MEA), And Segment Forecasts, 2013 - 2024
The global bone morphogenetic protein (BMP) market size is expected to reach over USD 644.6 million by 2024, based on a new report by Grand View Research, Inc. Increasing incidence of spinal fusion, trauma, and small bone surgeries coupled with demand for faster bone recovery are the key drivers affirming growth of BMP market.
Low back pain and spinal disc dislocation are some of the most common occupational hazards. Over 75% of such disorders require spinal surgery after noninvasive treatment options are unable to provide any relief. Minimally invasive surgery, shorter hospital stays, and fast recovery are common demands observed among patients. BMP has gained high acceptance among orthopedic surgeons in recent years owing to its ability to cater above mentioned benefits
Sport-related injuries, growing geriatric population, and increasing awareness about osteoinduction products as an alternative to bone grafting are other drivers accentuating market growth. BMP has reported outstanding results over bone graft, such as lack of donor morbidity, extensive surgical procedure, higher recovery time, pain & numbness, and high cost.
Further Key Findings From the Study Suggest:
rhBMP-2 and rhBMP-7 are the commercially available recombinant BMPs. rhBMP-2 is widely known for its high osteoinductive property for faster formation of bone and cartilage in bone fusion procedures
rhBMP-2 held more than half of the market share in 2015. Key attributes contributing toward its growth are high acceptance, wide range of applications, and easier availability in developing countries
rhBMP-7 on the other hand is expected to witness decline in market share over the forecast period owing to factors such as limited usage and discontinuation of OP-1from 2014 by Olympus
Spinal fusion held the largest share in 2015. Increasing cases of sport-related spinal injuries, wide range of product availability, easier usage, and long-term reliability are major factors for the aforementioned dominance.
North America held a significant share of over 65.0% in 2015. High number of orthopedic surgical procedures, and availability of favorable reimbursement policies are drivers that can be attributed to for largest share.
Low back pain and spinal disc dislocation are some of the most common occupational hazards. Over 75% of such disorders require spinal surgery after noninvasive treatment options are unable to provide any relief. Minimally invasive surgery, shorter hospital stays, and fast recovery are common demands observed among patients. BMP has gained high acceptance among orthopedic surgeons in recent years owing to its ability to cater above mentioned benefits
Sport-related injuries, growing geriatric population, and increasing awareness about osteoinduction products as an alternative to bone grafting are other drivers accentuating market growth. BMP has reported outstanding results over bone graft, such as lack of donor morbidity, extensive surgical procedure, higher recovery time, pain & numbness, and high cost.
Further Key Findings From the Study Suggest:
rhBMP-2 and rhBMP-7 are the commercially available recombinant BMPs. rhBMP-2 is widely known for its high osteoinductive property for faster formation of bone and cartilage in bone fusion procedures
rhBMP-2 held more than half of the market share in 2015. Key attributes contributing toward its growth are high acceptance, wide range of applications, and easier availability in developing countries
rhBMP-7 on the other hand is expected to witness decline in market share over the forecast period owing to factors such as limited usage and discontinuation of OP-1from 2014 by Olympus
Spinal fusion held the largest share in 2015. Increasing cases of sport-related spinal injuries, wide range of product availability, easier usage, and long-term reliability are major factors for the aforementioned dominance.
North America held a significant share of over 65.0% in 2015. High number of orthopedic surgical procedures, and availability of favorable reimbursement policies are drivers that can be attributed to for largest share.
CHAPTER 1 RESEARCH METHODOLOGY & SCOPE
1.1 Information Procurement
1.1.1 Purchased database:
1.1.2 GVR’s internal database
1.2 Research Methodology
1.3 Geographic Scope &Assumptions
1.4 Region-wise Market Calculation
1.4.1 Region-wise market: Base estimates
1.4.2 Global market: CAGR calculation
1.5 Region-based Segment Share Calculation
1.6 List of Secondary Sources
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Snapshot
CHAPTER 3 BONE MORPHOGENETIC PROTEIN MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Segmentation &Scope
3.1.1 Market driver analysis
3.1.1.1 Increasing base of target population
3.1.1.2 Increasing incidence of sports-related injuries
3.1.1.3 Rising awareness
3.1.1.4 Introduction of technological advancements
3.1.1.5 Increasing demand for minimally invasive medical procedures
3.1.2 Market restraint analysis
3.1.2.1 Availability of alternative treatments
3.1.2.1 High cost of procedure
3.2 Penetration &Growth Prospect Mapping
3.3 Bone Morphogenetic Protein- SWOT Analysis, by Factor (Political &Legal, Economic, and Technological)
3.4 Industry Analysis - Porter’s
3.5 Bone Morphogenetic Protein, Competitive Analysis
3.5.1 Company market share analysis
3.5.2 Competitive Heat map analysis
3.6 Technology Overview (Qualitative Analysis: Current and Future Aspects)
CHAPTER 4 BONE MORPHOGENETIC PROTEIN MARKET TYPE ESTIMATES & TREND ANALYSIS
4.1 Bone Morphogenetic Protein Market: Type Movement Analysis
4.2 rhBMP-2
4.2.1 rhBMP-2 market, 2013 - 2024 (USD Million)
4.3 rhBMP-7
4.3.1 rhBMP-7 market, 2013 - 2024 (USD Million)
CHAPTER 5 BONE MORPHOGENETIC PROTEIN MARKET APPLICATION ESTIMATES & TREND ANALYSIS
5.1 Bone morphogenetic protein market: Application movement analysis
5.2 Spinal Fusion
5.2.1 Spinal fusion market, 2013 - 2024 (USD Million)
5.3 Trauma
5.3.1 Trauma market, 2013 - 2024 (USD Million)
5.4 Reconstruction
5.4.1 Reconstruction market, 2013 - 2024 (USD Million)
5.5 Oral Maxillofacial
5.5.1 Oral maxillofacial market, 2013 - 2024 (USD Million)
CHAPTER 6 BONE MORPHOGENETIC PROTEIN MARKET REGIONAL ESTIMATES & TREND ANALYSIS, BY TYPE AND APPLICATION
6.1 Bone morphogenetic protein market share by region, 2015 & 2024
6.2 North America
6.2.1 North America bone morphogenetic protein market, 2013 - 2024 (USD Million)
6.2.2 U.S
6.2.2.1 U.S bone morphogenetic protein market, 2013 - 2024 (USD Million)
6.2.3 Canada
6.2.3.1 Canada bone morphogenetic protein market, 2013 - 2024 (USD Million)
6.3 Europe
6.3.1 Europe bone morphogenetic protein market, 2013 - 2024 (USD Million)
6.3.2 UK
6.3.2.1 UK bone morphogenetic protein market, 2013 - 2024 (USD Million)
6.3.3 Germany
6.3.3.1 Germany bone morphogenetic protein market, 2013 - 2024 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific bone morphogenetic protein market, 2013 - 2024 (USD Million)
6.4.2 Japan
6.4.2.1 Japan bone morphogenetic protein market, 2013 - 2024 (USD Million)
6.4.3 China
6.4.3.1 China bone morphogenetic protein market, 2013 - 2024 (USD Million)
6.4.4 India
6.4.4.1 India bone morphogenetic protein market, 2013 - 2024 (USD Million)
6.5 Latin America
6.5.1 Latin America bone morphogenetic protein market, 2013 - 2024 (USD Million)
6.5.2 Brazil
6.5.2.1 Brazil bone morphogenetic protein market, 2013 - 2024 (USD Million)
6.5.3 Mexico
6.5.3.1 Mexico bone morphogenetic protein market, 2013 - 2024 (USD Million)
6.6 MEA
6.6.1 MEA bone morphogenetic protein market, 2013 - 2024 (USD Million)
6.6.2 South Africa
6.6.2.1 South Africa bone morphogenetic protein market, 2013 - 2024 (USD Million)
CHAPTER 7 COMPETITIVE LANDSCAPE
7.1 Strategy Framework
7.2 Market Participation Categorization
7.3 Company Profiles
7.3.1 Medtronic Inc
7.3.1.1 Company overview
7.3.1.2 Financial performance
7.3.1.3 Product benchmarking
7.3.1.5 Strategic initiatives
7.3.2 Cellumed Co. Ltd
7.3.2.1 Company overview
7.3.2.2 Financial performance
7.3.2.3 Product benchmarking
7.3.2.4 Strategic initiatives
7.3.3 Stryker Corporation
7.3.3.1 Company overview
7.3.3.2 Financial performance
7.3.3.3 Product benchmarking
7.3.3.4 Strategic initiatives
7.3.4 Sigma Aldrich Corporation
7.3.4.1 Company overview
7.3.4.2 Financial performance
7.3.4.3 Product benchmarking
7.3.4.4 Strategic initiatives
7.3.5 ProSpec
7.3.5.1 Company overview
7.3.5.2 Financial performance
7.3.5.3 Product benchmarking
7.3.5.4 Strategic initiatives
7.3.6 Ember therapeutics Inc.
7.3.6.1 Company overview
7.3.6.2 Financial performance
7.3.6.3 Product benchmarking
7.3.6.4 Strategic initiatives
7.3.7 R&D Systems
7.3.7.1 Company overview
7.3.7.2 Financial performance
7.3.7.3 Product benchmarking
7.3.7.4 Strategic initiatives
7.3.8 Thermo Fischer Scientific
7.3.8.1 Company overview
7.3.8.2 Financial performance
7.3.8.3 Product benchmarking
7.3.8.4 Strategic initiatives
1.1 Information Procurement
1.1.1 Purchased database:
1.1.2 GVR’s internal database
1.2 Research Methodology
1.3 Geographic Scope &Assumptions
1.4 Region-wise Market Calculation
1.4.1 Region-wise market: Base estimates
1.4.2 Global market: CAGR calculation
1.5 Region-based Segment Share Calculation
1.6 List of Secondary Sources
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Snapshot
CHAPTER 3 BONE MORPHOGENETIC PROTEIN MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Segmentation &Scope
3.1.1 Market driver analysis
3.1.1.1 Increasing base of target population
3.1.1.2 Increasing incidence of sports-related injuries
3.1.1.3 Rising awareness
3.1.1.4 Introduction of technological advancements
3.1.1.5 Increasing demand for minimally invasive medical procedures
3.1.2 Market restraint analysis
3.1.2.1 Availability of alternative treatments
3.1.2.1 High cost of procedure
3.2 Penetration &Growth Prospect Mapping
3.3 Bone Morphogenetic Protein- SWOT Analysis, by Factor (Political &Legal, Economic, and Technological)
3.4 Industry Analysis - Porter’s
3.5 Bone Morphogenetic Protein, Competitive Analysis
3.5.1 Company market share analysis
3.5.2 Competitive Heat map analysis
3.6 Technology Overview (Qualitative Analysis: Current and Future Aspects)
CHAPTER 4 BONE MORPHOGENETIC PROTEIN MARKET TYPE ESTIMATES & TREND ANALYSIS
4.1 Bone Morphogenetic Protein Market: Type Movement Analysis
4.2 rhBMP-2
4.2.1 rhBMP-2 market, 2013 - 2024 (USD Million)
4.3 rhBMP-7
4.3.1 rhBMP-7 market, 2013 - 2024 (USD Million)
CHAPTER 5 BONE MORPHOGENETIC PROTEIN MARKET APPLICATION ESTIMATES & TREND ANALYSIS
5.1 Bone morphogenetic protein market: Application movement analysis
5.2 Spinal Fusion
5.2.1 Spinal fusion market, 2013 - 2024 (USD Million)
5.3 Trauma
5.3.1 Trauma market, 2013 - 2024 (USD Million)
5.4 Reconstruction
5.4.1 Reconstruction market, 2013 - 2024 (USD Million)
5.5 Oral Maxillofacial
5.5.1 Oral maxillofacial market, 2013 - 2024 (USD Million)
CHAPTER 6 BONE MORPHOGENETIC PROTEIN MARKET REGIONAL ESTIMATES & TREND ANALYSIS, BY TYPE AND APPLICATION
6.1 Bone morphogenetic protein market share by region, 2015 & 2024
6.2 North America
6.2.1 North America bone morphogenetic protein market, 2013 - 2024 (USD Million)
6.2.2 U.S
6.2.2.1 U.S bone morphogenetic protein market, 2013 - 2024 (USD Million)
6.2.3 Canada
6.2.3.1 Canada bone morphogenetic protein market, 2013 - 2024 (USD Million)
6.3 Europe
6.3.1 Europe bone morphogenetic protein market, 2013 - 2024 (USD Million)
6.3.2 UK
6.3.2.1 UK bone morphogenetic protein market, 2013 - 2024 (USD Million)
6.3.3 Germany
6.3.3.1 Germany bone morphogenetic protein market, 2013 - 2024 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific bone morphogenetic protein market, 2013 - 2024 (USD Million)
6.4.2 Japan
6.4.2.1 Japan bone morphogenetic protein market, 2013 - 2024 (USD Million)
6.4.3 China
6.4.3.1 China bone morphogenetic protein market, 2013 - 2024 (USD Million)
6.4.4 India
6.4.4.1 India bone morphogenetic protein market, 2013 - 2024 (USD Million)
6.5 Latin America
6.5.1 Latin America bone morphogenetic protein market, 2013 - 2024 (USD Million)
6.5.2 Brazil
6.5.2.1 Brazil bone morphogenetic protein market, 2013 - 2024 (USD Million)
6.5.3 Mexico
6.5.3.1 Mexico bone morphogenetic protein market, 2013 - 2024 (USD Million)
6.6 MEA
6.6.1 MEA bone morphogenetic protein market, 2013 - 2024 (USD Million)
6.6.2 South Africa
6.6.2.1 South Africa bone morphogenetic protein market, 2013 - 2024 (USD Million)
CHAPTER 7 COMPETITIVE LANDSCAPE
7.1 Strategy Framework
7.2 Market Participation Categorization
7.3 Company Profiles
7.3.1 Medtronic Inc
7.3.1.1 Company overview
7.3.1.2 Financial performance
7.3.1.3 Product benchmarking
7.3.1.5 Strategic initiatives
7.3.2 Cellumed Co. Ltd
7.3.2.1 Company overview
7.3.2.2 Financial performance
7.3.2.3 Product benchmarking
7.3.2.4 Strategic initiatives
7.3.3 Stryker Corporation
7.3.3.1 Company overview
7.3.3.2 Financial performance
7.3.3.3 Product benchmarking
7.3.3.4 Strategic initiatives
7.3.4 Sigma Aldrich Corporation
7.3.4.1 Company overview
7.3.4.2 Financial performance
7.3.4.3 Product benchmarking
7.3.4.4 Strategic initiatives
7.3.5 ProSpec
7.3.5.1 Company overview
7.3.5.2 Financial performance
7.3.5.3 Product benchmarking
7.3.5.4 Strategic initiatives
7.3.6 Ember therapeutics Inc.
7.3.6.1 Company overview
7.3.6.2 Financial performance
7.3.6.3 Product benchmarking
7.3.6.4 Strategic initiatives
7.3.7 R&D Systems
7.3.7.1 Company overview
7.3.7.2 Financial performance
7.3.7.3 Product benchmarking
7.3.7.4 Strategic initiatives
7.3.8 Thermo Fischer Scientific
7.3.8.1 Company overview
7.3.8.2 Financial performance
7.3.8.3 Product benchmarking
7.3.8.4 Strategic initiatives
LIST OF TABLES
TABLE 1 Country share estimation
TABLE 2 North America bone morphogenetic protein market estimates and forecasts, by type, 2013 - 2024 (USD Million)
TABLE 3 North America bone morphogenetic protein market estimates and forecasts, by application, 2013 - 2024 (USD Million)
TABLE 4 U.S. bone morphogenetic protein market estimates and forecasts, by type, 2013 - 2024 (USD Million)
TABLE 5 U.S. bone morphogenetic protein market estimates and forecasts, by application, 2013 - 2024 (USD Million)
TABLE 6 Canada bone morphogenetic protein market estimates and forecasts, by type, 2013 - 2024 (USD Million)
TABLE 7 Canada bone morphogenetic protein market estimates and forecasts, by application, 2013 - 2024 (USD Million)
TABLE 8 Europe bone morphogenetic protein market estimates and forecasts, by type, 2013 - 2024 (USD Million)
TABLE 9 Europe bone morphogenetic protein market estimates and forecasts, by application, 2013 - 2024 (USD Million)
TABLE 10 UK bone morphogenetic protein market estimates and forecasts, by type, 2013 - 2024 (USD Million)
TABLE 11 UK bone morphogenetic protein market estimates and forecasts, by application, 2013 - 2024 (USD Million)
TABLE 12 Germany bone morphogenetic protein market estimates and forecasts, by type, 2013 - 2024 (USD Million)
TABLE 13 Germany bone morphogenetic protein market estimates and forecasts, by application, 2013 - 2024 (USD Million)
TABLE 14 Asia Pacific bone morphogenetic protein market estimates and forecasts, by type, 2013 - 2024 (USD Million)
TABLE 15 Asia Pacific bone morphogenetic protein market estimates and forecasts, by application, 2013 - 2024 (USD Million)
TABLE 16 Japan bone morphogenetic protein market estimates and forecasts, by type, 2013 - 2024 (USD Million)
TABLE 17 Japan bone morphogenetic protein market estimates and forecasts, by application, 2013 - 2024 (USD Million)
TABLE 18 China bone morphogenetic protein market estimates and forecasts, by type, 2013 - 2024 (USD Million)
TABLE 19 China bone morphogenetic protein market estimates and forecasts, by application, 2013 - 2024 (USD Million)
TABLE 20 India bone morphogenetic protein market estimates and forecasts, by type, 2013 - 2024 (USD Million)
TABLE 21 India bone morphogenetic protein market estimates and forecasts, by application, 2013 - 2024 (USD Million)
TABLE 22 Latin America bone morphogenetic protein market estimates and forecasts, by type, 2013 - 2024 (USD Million)
TABLE 23 Latin America bone morphogenetic protein market estimates and forecasts, by application, 2013 - 2024 (USD Million)
TABLE 24 Brazil bone morphogenetic protein market estimates and forecasts, by type, 2013 - 2024 (USD Million)
TABLE 25 Brazil bone morphogenetic protein market estimates and forecasts, by application, 2013 - 2024 (USD Million)
TABLE 26 Mexico bone morphogenetic protein market estimates and forecasts, by type, 2013 - 2024 (USD Million)
TABLE 27 Mexico bone morphogenetic protein market estimates and forecasts, by application, 2013 - 2024 (USD Million)
TABLE 28 MEA bone morphogenetic protein market estimates and forecasts, by type, 2013 - 2024 (USD Million)
TABLE 29 MEA bone morphogenetic protein market estimates and forecasts, by application, 2013 - 2024 (USD Million)
TABLE 30 South Africa bone morphogenetic protein market estimates and forecasts, by type, 2013 - 2024 (USD Million)
TABLE 31 South Africa bone morphogenetic protein market estimates and forecasts, by application, 2013 - 2024 (USD Million)
TABLE 1 Country share estimation
TABLE 2 North America bone morphogenetic protein market estimates and forecasts, by type, 2013 - 2024 (USD Million)
TABLE 3 North America bone morphogenetic protein market estimates and forecasts, by application, 2013 - 2024 (USD Million)
TABLE 4 U.S. bone morphogenetic protein market estimates and forecasts, by type, 2013 - 2024 (USD Million)
TABLE 5 U.S. bone morphogenetic protein market estimates and forecasts, by application, 2013 - 2024 (USD Million)
TABLE 6 Canada bone morphogenetic protein market estimates and forecasts, by type, 2013 - 2024 (USD Million)
TABLE 7 Canada bone morphogenetic protein market estimates and forecasts, by application, 2013 - 2024 (USD Million)
TABLE 8 Europe bone morphogenetic protein market estimates and forecasts, by type, 2013 - 2024 (USD Million)
TABLE 9 Europe bone morphogenetic protein market estimates and forecasts, by application, 2013 - 2024 (USD Million)
TABLE 10 UK bone morphogenetic protein market estimates and forecasts, by type, 2013 - 2024 (USD Million)
TABLE 11 UK bone morphogenetic protein market estimates and forecasts, by application, 2013 - 2024 (USD Million)
TABLE 12 Germany bone morphogenetic protein market estimates and forecasts, by type, 2013 - 2024 (USD Million)
TABLE 13 Germany bone morphogenetic protein market estimates and forecasts, by application, 2013 - 2024 (USD Million)
TABLE 14 Asia Pacific bone morphogenetic protein market estimates and forecasts, by type, 2013 - 2024 (USD Million)
TABLE 15 Asia Pacific bone morphogenetic protein market estimates and forecasts, by application, 2013 - 2024 (USD Million)
TABLE 16 Japan bone morphogenetic protein market estimates and forecasts, by type, 2013 - 2024 (USD Million)
TABLE 17 Japan bone morphogenetic protein market estimates and forecasts, by application, 2013 - 2024 (USD Million)
TABLE 18 China bone morphogenetic protein market estimates and forecasts, by type, 2013 - 2024 (USD Million)
TABLE 19 China bone morphogenetic protein market estimates and forecasts, by application, 2013 - 2024 (USD Million)
TABLE 20 India bone morphogenetic protein market estimates and forecasts, by type, 2013 - 2024 (USD Million)
TABLE 21 India bone morphogenetic protein market estimates and forecasts, by application, 2013 - 2024 (USD Million)
TABLE 22 Latin America bone morphogenetic protein market estimates and forecasts, by type, 2013 - 2024 (USD Million)
TABLE 23 Latin America bone morphogenetic protein market estimates and forecasts, by application, 2013 - 2024 (USD Million)
TABLE 24 Brazil bone morphogenetic protein market estimates and forecasts, by type, 2013 - 2024 (USD Million)
TABLE 25 Brazil bone morphogenetic protein market estimates and forecasts, by application, 2013 - 2024 (USD Million)
TABLE 26 Mexico bone morphogenetic protein market estimates and forecasts, by type, 2013 - 2024 (USD Million)
TABLE 27 Mexico bone morphogenetic protein market estimates and forecasts, by application, 2013 - 2024 (USD Million)
TABLE 28 MEA bone morphogenetic protein market estimates and forecasts, by type, 2013 - 2024 (USD Million)
TABLE 29 MEA bone morphogenetic protein market estimates and forecasts, by application, 2013 - 2024 (USD Million)
TABLE 30 South Africa bone morphogenetic protein market estimates and forecasts, by type, 2013 - 2024 (USD Million)
TABLE 31 South Africa bone morphogenetic protein market estimates and forecasts, by application, 2013 - 2024 (USD Million)
LIST OF FIGURES
FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Value chain based sizing & forecasting
FIG. 4 QFD modeling for market share assessment
FIG. 5 Market summary
FIG. 6 Market trends &outlook
FIG. 7 Market segmentation & scope
FIG. 8 Market driver relevance analysis (Current & future impact)
FIG. 9 Population by age group (in thousands), 2015 & 2050
FIG. 10 Global increase in osteoporosis cases, 1990 - 2050 (Million)
FIG. 11 Injuries by sport (Percentage)
FIG. 12 Market restraint relevance analysis (Current & future impact)
FIG. 13 Penetration & growth prospect mapping
FIG. 14 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 15 Porter’s Five Forces Analysis
FIG. 16 Company market share analysis (2015)
FIG. 17 Competitive Heat Map analysis
FIG. 18 Bone morphogenetic protein market type outlook key takeaways
FIG. 19 Bone morphogenetic protein market: Type movement analysis
FIG. 20 Global rhBMP-2 market, 2013 - 2024 (USD Million)
FIG. 21 Global rhBMP-7 market, 2013 - 2024 (USD Million)
FIG. 22 Bone market application outlook key takeaways
FIG. 23 Bone morphogenetic protein market: Application movement analysis
FIG. 24 Global spinal fusion market, 2013 - 2024 (USD Million)
FIG. 25 Global trauma market, 2013 - 2024 (USD Million)
FIG. 26 Global reconstruction market, 2013 - 2024 (USD Million)
FIG. 27 Global oral maxillofacial market, 2013 - 2024 (USD Million)
FIG. 28 Regional market place: Key takeaways
FIG. 29 Regional outlook, 2015 & 2024
FIG. 30 North America bone morphogenetic protein market, 2013 - 2024 (USD Million)
FIG. 31 U.S. bone morphogenetic protein market, 2013 - 2024 (USD Million)
FIG. 32 Canada bone morphogenetic protein market, 2013 - 2024 (USD Million)
FIG. 33 Europe bone morphogenetic protein market, 2013 - 2024 (USD Million)
FIG. 34 UK bone morphogenetic protein market, 2013 - 2024 (USD Million)
FIG. 35 Germany bone morphogenetic protein market, 2013 - 2024 (USD Million)
FIG. 36 Asia Pacific bone morphogenetic protein market, 2013 - 2024 (USD Million)
FIG. 37 Japan bone morphogenetic protein market, 2013 - 2024 (USD Million)
FIG. 38 China bone morphogenetic protein market, 2013 - 2024 (USD Million)
FIG. 39 India bone morphogenetic protein market, 2013 - 2024 (USD Million)
FIG. 40 Latin America bone morphogenetic protein market, 2013 - 2024 (USD Million)
FIG. 41 Brazil bone morphogenetic protein market, 2013 - 2024 (USD Million)
FIG. 42 Mexico bone morphogenetic protein market, 2013 - 2024 (USD Million)
FIG. 43 MEA bone morphogenetic protein market, 2013 - 2024 (USD Million)
FIG. 44 South Africa bone morphogenetic protein market, 2013 - 2024 (USD Million)
FIG. 45 Strategy framework
FIG. 46 Participant categorization
FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Value chain based sizing & forecasting
FIG. 4 QFD modeling for market share assessment
FIG. 5 Market summary
FIG. 6 Market trends &outlook
FIG. 7 Market segmentation & scope
FIG. 8 Market driver relevance analysis (Current & future impact)
FIG. 9 Population by age group (in thousands), 2015 & 2050
FIG. 10 Global increase in osteoporosis cases, 1990 - 2050 (Million)
FIG. 11 Injuries by sport (Percentage)
FIG. 12 Market restraint relevance analysis (Current & future impact)
FIG. 13 Penetration & growth prospect mapping
FIG. 14 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 15 Porter’s Five Forces Analysis
FIG. 16 Company market share analysis (2015)
FIG. 17 Competitive Heat Map analysis
FIG. 18 Bone morphogenetic protein market type outlook key takeaways
FIG. 19 Bone morphogenetic protein market: Type movement analysis
FIG. 20 Global rhBMP-2 market, 2013 - 2024 (USD Million)
FIG. 21 Global rhBMP-7 market, 2013 - 2024 (USD Million)
FIG. 22 Bone market application outlook key takeaways
FIG. 23 Bone morphogenetic protein market: Application movement analysis
FIG. 24 Global spinal fusion market, 2013 - 2024 (USD Million)
FIG. 25 Global trauma market, 2013 - 2024 (USD Million)
FIG. 26 Global reconstruction market, 2013 - 2024 (USD Million)
FIG. 27 Global oral maxillofacial market, 2013 - 2024 (USD Million)
FIG. 28 Regional market place: Key takeaways
FIG. 29 Regional outlook, 2015 & 2024
FIG. 30 North America bone morphogenetic protein market, 2013 - 2024 (USD Million)
FIG. 31 U.S. bone morphogenetic protein market, 2013 - 2024 (USD Million)
FIG. 32 Canada bone morphogenetic protein market, 2013 - 2024 (USD Million)
FIG. 33 Europe bone morphogenetic protein market, 2013 - 2024 (USD Million)
FIG. 34 UK bone morphogenetic protein market, 2013 - 2024 (USD Million)
FIG. 35 Germany bone morphogenetic protein market, 2013 - 2024 (USD Million)
FIG. 36 Asia Pacific bone morphogenetic protein market, 2013 - 2024 (USD Million)
FIG. 37 Japan bone morphogenetic protein market, 2013 - 2024 (USD Million)
FIG. 38 China bone morphogenetic protein market, 2013 - 2024 (USD Million)
FIG. 39 India bone morphogenetic protein market, 2013 - 2024 (USD Million)
FIG. 40 Latin America bone morphogenetic protein market, 2013 - 2024 (USD Million)
FIG. 41 Brazil bone morphogenetic protein market, 2013 - 2024 (USD Million)
FIG. 42 Mexico bone morphogenetic protein market, 2013 - 2024 (USD Million)
FIG. 43 MEA bone morphogenetic protein market, 2013 - 2024 (USD Million)
FIG. 44 South Africa bone morphogenetic protein market, 2013 - 2024 (USD Million)
FIG. 45 Strategy framework
FIG. 46 Participant categorization
